Post-irradiation malignant mesothelioma

Cancer
A CavazzaT V Colby

Abstract

Approximately 30 patients with malignant mesothelioma following radiotherapy have been described. Population-based studies of this occurrence have not been reported. Patients with malignant mesothelioma of the pleura were collected. All of the patients had a prior cancer and had received radiotherapy to the region in which the malignant mesothelioma developed. Data from the National Cancer Institute's Surveillance, Epidemiology and End Results Program and the Connecticut Tumor Registry were evaluated for cases of malignant mesothelioma of the pleura occurring in patients with a previous cancer. The literature on post-irradiation malignant mesotheliomas was reviewed. Eight patients (4 men, 4 women) with malignant mesothelioma occurring in sites of radiotherapy for a prior tumor were identified. The mean age at diagnosis of mesothelioma was 45 years (range: 22-78 years), and the average interval between radiotherapy and the mesothelioma was 21 years (range: 11-29 years). Three of the patients had also received chemotherapy. Histologically, the mesotheliomas were epithelial in five cases, biphasic in one, and sarcomatous in one. One hundred forty-two patients were identified in the epidemiologic survey. The majority were men (89%)...Continue Reading

References

Jan 1, 1976·Journal of Surgical Oncology·T L BabcockR S Bothwell
Sep 2, 1992·Journal of the National Cancer Institute·M Andersson, H H Storm
Jun 1, 1991·Thorax·Y LermanA Yellin
Aug 1, 1986·American Journal of Clinical Pathology·M B AustinV L Roggli
Jan 14, 1988·The New England Journal of Medicine·M A TuckerS A Rosenberg
Mar 1, 1985·Cancer·A P EfremidisA P Chahinian
Oct 1, 1985·Environmental Health Perspectives·J C McDonald
Jun 1, 1972·Health Physics·C L Sanders, T A Jackson
Dec 11, 1967·Annals of the New York Academy of Sciences·S Dahlgren
Jul 15, 1984·Cancer·K H AntmanG Vawter
Sep 1, 1984·Cancer·J T PetersonP A Buffler
Jul 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W J TesterV T DeVita
Nov 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H AntmanL Weinstein
Jun 1, 1982·Cancer·J BrennerR B Golbey
May 21, 1982·JAMA : the Journal of the American Medical Association·F P Li, J F Fraumeni
Jan 1, 1982·American Journal of Industrial Medicine·A HirschJ Bignon
Oct 1, 1994·The American Journal of Medicine·J HofmannM J Warhol

❮ Previous
Next ❯

Citations

Sep 24, 1999·Occupational and Environmental Medicine·G Hillerdal
Jul 30, 2008·Journal of Carcinogenesis·Shoshana J Weiner, Siyamek Neragi-Miandoab
Aug 19, 2008·Current Treatment Options in Oncology·Haining YangMichele Carbone
Mar 1, 2012·Archives of Pathology & Laboratory Medicine·Bharat Jasani, Allen Gibbs
Sep 13, 2008·Journal of Cancer Research and Clinical Oncology·Shoshana J Weiner, Siyamek Neragi-Miandoab
May 16, 2009·Cancer Causes & Control : CCC·Julie E GoodmanPeter A Valberg
Apr 7, 2015·Archives of Pathology & Laboratory Medicine·Xin LiVictor L Roggli
Apr 29, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kyoko YamashitaShinya Toyokuni
Sep 22, 2005·Journal of the National Cancer Institute·Lois B TravisEthel S Gilbert
Nov 20, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lucian R ChirieacDavid J Sugarbaker
Jan 1, 1997·Cancer·A S PappoC B Pratt
Aug 4, 2012·International Journal of Cancer. Journal International Du Cancer·Nicholas de KlerkAw Bill Musk
Feb 5, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Marie-Claude Jaurand, Jocelyne Fleury-Feith
Jan 6, 2010·British Medical Bulletin·R M Rudd
Jul 11, 2019·International Journal of Radiation Biology·Michael T MummaWilliam J Blot
Feb 24, 2009·Blood·Marie L De BruinFlora E van Leeuwen
Feb 23, 2007·Cancer·M Jane TetaMeghan E Wagner
Jul 30, 2017·Cancer Causes & Control : CCC·Ellen T ChangM Jane Teta
Feb 23, 2019·Current Treatment Options in Oncology·Vincenzo Di NoiaEttore D'Argento
Nov 16, 2011·Head & Neck·Suraya H SinonGregory J Seymour
Aug 23, 2020·The American Journal of Surgical Pathology·Tala MujahedBrandon T Larsen
Jan 22, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Rachelle AsciakNajiib M Rahman
Feb 25, 2021·International Journal of Surgical Pathology·Giulio RossiFabio Davoli
Oct 6, 2020·Thoracic Surgery Clinics·Yin P Hung, Lucian R Chirieac
Jun 3, 2021·Journal of Clinical Medicine·Emanuele VitaEmilio Bria
Jun 3, 2021·Journal of Clinical Medicine·Giulio RossiFilippo Lococo
Feb 4, 2011·Cancer Treatment Reviews·P A ZucaliA Santoro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.